HIV medicines, known as antiretroviral therapy or ART, work by targeting different stages of viral replication. Each drug class has a specific mechanism, and healthcare professionals select medicines according to treatment guidelines, individual health needs, and potential drug resistance. Combining medicines from different classes can help suppress HIV and support long-term health.
The main HIV drug classes include:
These classes differ in their targets, mechanisms of action, possible side effects, and potential interactions with other medicines.
HIV treatment strategies are designed to suppress viral replication and maintain immune system function. Although combination therapy remains central to HIV treatment, the medicines and regimen formats selected can differ according to a person's medical history and treatment requirements. Healthcare professionals consider factors such as previous antiretroviral exposure, drug resistance, other medical conditions, and medication interactions.
For many adults beginning HIV treatment, guidelines recommend an initial regimen containing an integrase strand transfer inhibitor combined with other antiretroviral medicines. The specific regimen depends on clinical circumstances and applicable treatment recommendations.
Common treatment considerations include:
Treatment may need to be adjusted when a person experiences side effects, develops drug resistance, has other medical conditions, or takes medicines that interact with antiretroviral therapy. A healthcare professional evaluates these factors before selecting or changing a regimen.
Important factors in treatment planning include:
Oral antiretroviral therapy is available in single tablet and multiple tablet formats. Some treatment options also use long acting injectable medicines. For example, cabotegravir and rilpivirine are available together as an injectable treatment for eligible individuals under applicable clinical guidelines.
Oral and injectable approaches differ in their administration schedules, eligibility requirements, and monitoring considerations. Treatment selection should be based on clinical assessment rather than convenience alone.
Understanding HIV drug classes helps explain how antiretroviral medicines target different stages of the viral life cycle. NRTIs, NNRTIs, INSTIs, protease inhibitors, entry inhibitors, and capsid inhibitors have distinct mechanisms and treatment applications. HIV treatment strategies vary according to individual medical needs, treatment history, drug interactions, and clinical guidelines. Regular medical follow-up and adherence to prescribed therapy remain important components of HIV management.